I actually see it as viable.
The purchasers can move forward with Trof 1.0 - provide the funds for NEU to develop and bring it to market - in the same instance Tof 2.0 can move forward with the cash made available - there would have to be an option for first right of refusal from the purchaser - so I reckon they could have the best of both worlds.
- Forums
- ASX - By Stock
- NEU
- Possible outcomes?
NEU
neuren pharmaceuticals limited
Add to My Watchlist
2.00%
!
$16.66
Possible outcomes?, page-7
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
